Back to top
more

Ecolab (ECL)

(Delayed Data from NYSE)

$243.17 USD

243.17
1,025,980

+0.90 (0.37%)

Updated Jul 19, 2024 04:00 PM ET

After-Market: $243.17 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Suzano (SUZ) to Buy 2 Mills From Pactiv Evergreen for $110M

by Zacks Equity Research

Suzano (SUZ) signs an agreement with Pactiv Evergreen to acquire two of its US industrial facilities.

Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for PHO

Should You Invest in the Invesco Water Resources ETF (PHO)?

by Zacks Equity Research

Sector ETF report for PHO

Barrick (GOLD) Announces Strategic Plans for Loulo-Gounkoto

by Zacks Equity Research

Barrick (GOLD) emphasizes the importance of sustaining the Loulo-Gounkoto gold mining complex, with a significant economic contribution to Mali.

3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now

by Zacks Equity Research

Avantor's (AVTR) strong product portfolio raises optimism about the stock.

Orthofix Medical's (OFIX) Fitbone System Gets FDA Clearance

by Zacks Equity Research

Orthofix Medical (OFIX) announces the FDA clearance and first U.S. implant of the Fitbone Transport and Lengthening System, used to treat large bone defects in the femur and tibia.

Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit

by Zacks Equity Research

Masimo's (MASI) second-quarter 2024 results are likely to reflect the strength in the Healthcare business.

Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028

by Zacks Equity Research

The recall of Inspire Medical 's (INSP) Inspire IV Implantable Pulse Generators might dampen the company's future sales.

Royal Gold (RGLD) Issues Stream Segment Sales Update for Q2

by Zacks Equity Research

Royal Gold (RGLD) sells 52,600 gold equivalent ounces in the June-end quarter of 2024.

DuPont (DD) Tyvek Richmond Facility Gets ISCC+ Certification

by Zacks Equity Research

DuPont's (DD) global integration of ISCC PLUS certification into Tyvek production coincides with the company's commitment to empowering clients on their road to net zero emissions.

Stryker (SYK) Gains 11.6% YTD: What's Driving the Stock?

by Zacks Equity Research

Styker's (SYK) flagship Mako Total Knee Platform and a diversified product portfolio raise optimism about the stock.

Here's Why You Should Add H.B. Fuller (FUL) to Your Portfolio

by Zacks Equity Research

H.B. Fuller (FUL) presents a substantial investment opportunity with robust earnings outperformance and promising growth prospects.

ArcelorMittal (MT)-Partners Begin Carbon Capture Trial in Ghent

by Zacks Equity Research

ArcelorMittal (MT), MHI and D-CRBN are trialing plasma technology at Gent to convert CO2 into carbon monoxide for steel and chemical production, aiming to reduce emissions.

BASF (BASFY) Expands Sodium Methylate Capacity in South America

by Zacks Equity Research

This capacity increase is another step in BASF's (BASFY) business expansion for sodium methylate in South America, demonstrating the company's commitment to its customers and the South American biodiesel market.

Yara (YARIY) and Scatec Ink Renewable Ammonia Offtake Deal

by Zacks Equity Research

This project will bolster Yara's (YARIY) renewable ammonia sourcing portfolio and allow it to reliably serve its customers across several markets.

Baxter (BAX) Recovers After Life2000 Ventilation Systems Recall

by Zacks Equity Research

Baxter (BAX) recalls Life2000 ventilators due to damaged battery charger dongles, posing a risk of device failure

Hawkins (HWKN) Strengthens Water Treatment With Wofford Buy

by Zacks Equity Research

Hawkins (HWKN) acquires Wofford Water Service, strengthening its presence in the southern U.S. and expanding its Water Treatment business in Mississippi.

Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital

by Zacks Equity Research

Smith & Nephew (SNN) eyes future growth as Cevian Capital purchases a 5% stake in the company.

Sandstorm Gold (SAND) Posts Y/Y Preliminary Q2 Revenue Decline

by Zacks Equity Research

Sandstorm Gold's (SAND) preliminary revenues fall 16.9% year over year, while the cash operating margin improves 17.1% in the second quarter.

Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now

by Zacks Equity Research

Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.

Arkema (ARKAY) Gets ISCC+ for Powder Coating Resins Facility

by Zacks Equity Research

The facility of Arkema (ARKAY) includes a polyester resin production line and a cutting-edge R&D laboratory dedicated to increasing the sustainability and performance of powder coating materials

Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now

by Zacks Equity Research

BD's (BDX) robust product portfolio raises optimism about the stock.

Masimo (MASI) Fights Politan in a Bid to Retain CEO on Board

by Zacks Equity Research

Will Masimo (MASI) lose its CEO in its fight against activist investor Politan Capital Management? The company's management and employees want Joe Kiani to continue as the CEO.

DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs

by Zacks Equity Research

Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.

Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial

by Zacks Equity Research

Microbot Medical's (MBOT) LIBERTY Endovascular Robotic System trial expands to Baptist Hospital of Miami, promising advancements in clinical outcomes and endovascular procedures.